Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamberto, C.
Right arrow Articles by Clerici, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamberto, C.
Right arrow Articles by Clerici, C.
(Chest. 2004;125:2061-2068.)
© 2004 American College of Chest Physicians

Membrane and Capillary Blood Components of Diffusion Capacity of the Lung for Carbon Monoxide in Pulmonary Sarcoidosis*

Relation to Exercise Gas Exchange

Christine Lamberto, MD; Hilario Nunes, MD; Philippe Le Toumelin, MD; Florence Duperron, MD; Dominique Valeyre, MD and Christine Clerici, MD, PhD

* From the Departments of Physiology (Drs. Lamberto, Duperron, and Clerici), Respiratory Medicine (Drs. Nunes and Valeyre), and Anesthesiology (Dr. Le Toumelin), Assistance Publique/Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France.

Correspondence to: Christine Lamberto, MD, Department of Physiology, Hôpital Avicenne, 125 route de Stalingrad 93012 Bobigny, France; e-mail: christine.lamberto{at}avc.ap-hop-paris.fr

Background: Resting pulmonary diffusing capacity of the lung for carbon monoxide (DLCO) is known to be the best predictor of arterial desaturation during exercise in patients with sarcoidosis. However, the relative contribution of each of the two components of DLCO—alveolar membrane diffusing capacity (Dm) and pulmonary capillary blood volume (Vc)—remains unclear.

Study objectives: To evaluate which component is responsible for the decrease of resting DLCO in patients with sarcoidosis, and to determine which resting pulmonary function test, including Dm and Vc, is the best predictor of gas exchange abnormalities during submaximal exercise.

Design: Prospective analysis of patients referred to our department of respiratory medicine.

Patients: Twenty four patients with pulmonary sarcoidosis were separated into two groups according to chest radiographic findings: group 1, stages 2 and 3 (n = 15); group 2, stage 4 (n = 9). All the patients completed pulmonary function tests (flows, volumes, single-breath DLCO, transfer coefficient [Ka], Dm, Vc) and submaximal exercise (two steady-state levels of mild and moderate exercise corresponding respectively to a target oxygen consumption of approximately 10 to 15 mL/min/kg).

Results: DLCO was reduced in the two groups (group 1, 63 ± 16% of predicted; group 2, 64 ± 16% of predicted). Dm was severely decreased (group 1, 58 ± 24% of predicted; group 2, 51 ± 15% of predicted), whereas Vc was unchanged or only mildly decreased (group 1, 81 ± 18% of predicted; group 2, 85 ± 28% of predicted). Whatever the group of patients and the exercise level, Dm and DLCO were the strongest predictors (p < 0.001) of gas exchange abnormalities. Ka or volumes were weak predictors, and Vc or flows were not related with exercise gas exchange.

Conclusions: This study demonstrates that a decrease in Dm mostly accounts for resting DLCO reduction, and that Dm as well as DLCO are highly predictive of gas exchange abnormalities at exercise in patients with sarcoidosis.

Key Words: exercise testing • membrane diffusing capacity • pulmonary capillary blood volume • pulmonary diffusing capacity • pulmonary gas exchange • pulmonary sarcoidosis




This article has been cited by other articles:


Home page
ChestHome page
I. van der Lee, P. Zanen, J. C. Grutters, R. J. Snijder, and J. M.M. van den Bosch
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension.
Chest, February 1, 2006; 129(2): 378 - 383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.